Literature DB >> 6607219

Virulence factors of Haemophilus ducreyi.

J A Odumeru, G M Wiseman, A R Ronald.   

Abstract

We investigated the susceptibility of virulent and avirulent strains of Haemophilus ducreyi to the bactericidal activity of normal human serum and to phagocytosis and killing by human polymorphonuclear leukocytes (PMNL). Strains were defined as virulent if intradermal inoculation into a rabbit produced a typical necrotic lesion. Nonvirulent strains produced no cutaneous lesions in rabbits. Virulent strains were resistant to the complement-mediated lethal action of normal human and rabbit sera, whereas avirulent strains were susceptible (greater than 95% kill, 60 min). Virulent strains were relatively resistant to phagocytosis and killing by human PMNL, in contrast to the avirulent strains. In past studies polymyxin resistance has been correlated with virulence in H. ducreyi. In our studies, polymyxin resistance could not be correlated with virulence, since polymyxin-sensitive mutants obtained from polymyxin-resistant parent strains remained virulent for rabbits and resistant to bactericidal action of normal serum and phagocytosis and killing by human PMNL. Similarly, polymyxin-resistant mutants obtained from polymyxin-sensitive parent strains remained avirulent for rabbits and susceptible to bactericidal action of normal serum and PMNL. The acquisition of polymyxin resistance was accompanied by the loss of a 47,000-molecular-weight protein. The association of serum resistance and resistance to phagocytosis and killing by human PMNL with virulent strains, as defined by the rabbit intradermal test, suggests that these factors may mediate the pathogenicity of H. ducreyi.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6607219      PMCID: PMC264342          DOI: 10.1128/iai.43.2.607-611.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  Serum bactericidal actions.

Authors:  L H MUSCHEL
Journal:  Ann N Y Acad Sci       Date:  1960-11-21       Impact factor: 5.691

2.  Effects of penicillin G in vitro on Hemophilus ducreyi.

Authors:  W E DEACON; S SINGER
Journal:  Public Health Rep       Date:  1956-11       Impact factor: 2.792

3.  Replica plating and indirect selection of bacterial mutants.

Authors:  J LEDERBERG; E M LEDERBERG
Journal:  J Bacteriol       Date:  1952-03       Impact factor: 3.490

4.  The complement system in host defense and inflammation.

Authors:  M M Frank
Journal:  Rev Infect Dis       Date:  1979 May-Jun

5.  Serum resistance associated with virulence in Yersinia enterocolitica.

Authors:  C H Pai; L DeStephano
Journal:  Infect Immun       Date:  1982-02       Impact factor: 3.441

6.  In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease of childhood.

Authors:  P G Quie; J G White; B Holmes; R A Good
Journal:  J Clin Invest       Date:  1967-04       Impact factor: 14.808

7.  Gonococci causing disseminated gonococcal infection are resistant to the bactericidal action of normal human sera.

Authors:  G K Schoolnik; T M Buchanan; K K Holmes
Journal:  J Clin Invest       Date:  1976-11       Impact factor: 14.808

8.  Subtyping isolates of Haemophilus influenzae type b by outer-membrane protein profiles.

Authors:  S J Barenkamp; R S Munson; D M Granoff
Journal:  J Infect Dis       Date:  1981-05       Impact factor: 5.226

9.  Differential complement resistance mediates virulence of Haemophilus influenzae type b.

Authors:  A Sutton; R Schneerson; S Kendall-Morris; J B Robbins
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

10.  A rapid micro method for the simultaneous determination of phagocytic-microbiocidal activity of human peripheral blood leukocytes in vitro.

Authors:  D L Smith; F Rommel
Journal:  J Immunol Methods       Date:  1977       Impact factor: 2.303

View more
  25 in total

Review 1.  Immunopathogenesis of Haemophilus ducreyi infection (chancroid).

Authors:  Stanley M Spinola; Margaret E Bauer; Robert S Munson
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

2.  Haemophilus ducreyi inhibits phagocytosis by U-937 cells, a human macrophage-like cell line.

Authors:  G E Wood; S M Dutro; P A Totten
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

3.  Killing of dsrA mutants of Haemophilus ducreyi by normal human serum occurs via the classical complement pathway and is initiated by immunoglobulin M binding.

Authors:  Malikah Abdullah; Igor Nepluev; Galyna Afonina; Sanjay Ram; Peter Rice; William Cade; Christopher Elkins
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

4.  Identification of tandem genes involved in lipooligosaccharide expression by Haemophilus ducreyi.

Authors:  M K Stevens; J Klesney-Tait; S Lumbley; K A Walters; A M Joffe; J D Radolf; E J Hansen
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

5.  DNA probes for the identification of Haemophilus ducreyi.

Authors:  L M Parsons; M Shayegani; A L Waring; L H Bopp
Journal:  J Clin Microbiol       Date:  1989-07       Impact factor: 5.948

6.  Cloning and characterization of the lipooligosaccharide galactosyltransferase II gene of Haemophilus ducreyi.

Authors:  S Sun; B Schilling; L Tarantino; M V Tullius; B W Gibson; R S Munson
Journal:  J Bacteriol       Date:  2000-04       Impact factor: 3.490

7.  Cloning, overexpression, purification, and immunobiology of an 85-kilodalton outer membrane protein from Haemophilus ducreyi.

Authors:  K L Thomas; I Leduc; B Olsen; C E Thomas; D W Cameron; C Elkins
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

8.  Use of tissue culture and animal models to identify virulence-associated traits of Haemophilus ducreyi.

Authors:  M J Alfa; M K Stevens; P DeGagne; J Klesney-Tait; J D Radolf; E J Hansen
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

9.  Characterization of the hemolytic activity of Haemophilus ducreyi.

Authors:  P A Totten; D V Norn; W E Stamm
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

Review 10.  Chancroid and Haemophilus ducreyi: an update.

Authors:  D L Trees; S A Morse
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.